Clinical Trials
60
Active:6
Completed:34
Trial Phases
5 Phases
Phase 1:5
Phase 2:8
Phase 3:12
+2 more phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (52 trials with phase data)• Click on a phase to view related trials
Not Applicable
26 (50.0%)Phase 3
12 (23.1%)Phase 2
8 (15.4%)Phase 1
5 (9.6%)Phase 4
1 (1.9%)Low Dose Radiotherapy for Heart Failure
Phase 1
Not yet recruiting
- Conditions
- Heart Failure - NYHA II - IV
- First Posted Date
- 2025-06-25
- Last Posted Date
- 2025-06-25
- Lead Sponsor
- Hospital do Coracao
- Target Recruit Count
- 10
- Registration Number
- NCT07037524
- Locations
- 🇧🇷
Hcor / Associação Beneficente Síria, São Paulo, Brazil
LIQUID BIOPSY FOCUSING ON CIRCULATING TUMOR CELLS AND CIRCULATING TUMOR DNA AS PRECISION MEDICINE IN GASTROINTESTINAL TUMORS
Active, not recruiting
- Conditions
- Cancer of RectumCancer of PancreasCancer of Stomach
- First Posted Date
- 2025-04-23
- Last Posted Date
- 2025-04-27
- Lead Sponsor
- Hospital do Coracao
- Target Recruit Count
- 273
- Registration Number
- NCT06940778
- Locations
- 🇧🇷
Hcor, São Paulo, SP, Brazil
Evaluation of a POlypill and Colchicine for Risk Reduction in Patients With Established Atherosclerotic Cardiovascular Disease
Phase 3
Not yet recruiting
- Conditions
- Atherothrombotic DiseasesAtherosclerotic Cardiovascular Disease (ASCVD)
- Interventions
- Drug: Cardiovascular PolypillDrug: Colchicine-placebo 0.5 mgDrug: Usual Care Group
- First Posted Date
- 2025-04-16
- Last Posted Date
- 2025-04-16
- Lead Sponsor
- Hospital do Coracao
- Target Recruit Count
- 7713
- Registration Number
- NCT06930885
CRYoablation for Small Tumors As Local Treatment - SIX Trial
Phase 3
Recruiting
- Conditions
- Breast CancerBreast Neoplasm
- First Posted Date
- 2025-02-21
- Last Posted Date
- 2025-06-26
- Lead Sponsor
- Hospital do Coracao
- Target Recruit Count
- 750
- Registration Number
- NCT06839001
- Locations
- 🇧🇷
Research Institute - Hospital do Coracao, São Paulo, Brazil
Use of Vasopressin in Patients at High Risk of Acute Kidney Injury Admitted to the ICU
Phase 2
Recruiting
- Conditions
- Critical Illness
- Interventions
- Other: 0,9% saline solution
- First Posted Date
- 2024-08-09
- Last Posted Date
- 2025-04-13
- Lead Sponsor
- Hospital do Coracao
- Target Recruit Count
- 60
- Registration Number
- NCT06547892
- Locations
- 🇧🇷
Matheus Liguori Feliciano da Silva, São Paulo, SP, Brazil
- Prev
- 1
- 2
- 3
- 4
- 5
- 12
- Next
News
No news found